Plasma AGE - peptides and C - peptide in <font color="red">early_2</font> <font color="red">-_2</font> <font color="red">stage_2</font> <font color="red">diabetic_2</font> <font color="red">nephropathy_2</font> <font color="red">patients_2</font> on thiamine and pyridoxine therapy . 
<br>
<br> AIM The aim of the study was to evaluate circulatory AGE - peptide levels in <font color="red">diabetic_2</font> <font color="red">nephropathy_2</font> and to observe the effects of thiamine ( vitamin B1 ) and pyridoxine ( vitamin B6 ) therapy . 
<br> METHODS <font color="red">Type_2</font> <font color="red">2_2</font> <font color="red">diabetic_2</font> <font color="red">patients_2</font> <font color="red">(_2</font> <font color="red">N.=57_2</font> <font color="red">)_2</font> <font color="red">were_1</font> <font color="red">divided_1</font> <font color="red">into_1</font> <font color="red">two_1</font> <font color="red">groups_1</font> <font color="red">as_1</font> <font color="red">"_1</font> <font color="red">with_1</font> <font color="red">nephropathy_1</font> <font color="red">"_1</font> <font color="red">(_1</font> <font color="red">N.=27_1</font> <font color="red">)_1</font> <font color="red">and_1</font> <font color="red">"_1</font> <font color="red">without_1</font> <font color="red">nephropathy_1</font> <font color="red">"_1</font> <font color="red">(_1</font> <font color="red">N.=30_1</font> <font color="red">)_1</font> <font color="red">._1</font> <font color="red">Diabetic_2</font> <font color="red">nephropathy_2</font> <font color="red">patients_2</font> were treated with either B6 ( N.=12 ) ( 250 mg / day ) or B1+B6 ( N.=15 ) ( 250 mg / day , each ) for five months . At the beginning and the end of the experimentation period , glucose , HbA1c , triglyceride , cholesterol , insulin , C - peptide , thiamine pyrophosphate , pyridoxal phosphate and AGE- peptides were measured . 
<br> RESULTS AGE - peptides were higher in the <font color="red">diabetic_1</font> <font color="red">group_1</font> <font color="red">with_1</font> <font color="red">nephropathy_1</font> than <font color="red">without_1</font> <font color="red">nephropathy_1</font> ( P=0.005 ) . Within five months AGE - peptides increased in the diabetic group without nephropathy ( P=0.042 ) but not in the group <font color="red">with_1</font> <font color="red">nephropathy_1</font> treated either with B1+B6 or B6 . In B6 treated group a substantial decrease was observed in HbA1c ( P=0.033 ) . B1+B6 or B6 treatment both caused an increase in C - peptide ( P=0.006 , P=0.004 ) . 
<br> CONCLUSION Among the parameters measured , plasma AGE - peptides was the only parameter found to be higher in <font color="red">type_2</font> <font color="red">2_2</font> <font color="red">diabetes_2</font> <font color="red">mellitus_2</font> <font color="red">patients_2</font> <font color="red">"_1</font> <font color="red">with_1</font> <font color="red">nephropathy_1</font> <font color="red">"_1</font> than " <font color="red">without_1</font> <font color="red">nephropathy_1</font> <font color="red">"_1</font> . However , <font color="red">patients_2</font> <font color="red">with_2</font> <font color="red">nephropathy_2</font> treated with B1+B6 or B6 did not display any further increase in AGE - peptides within five months . Both of the treatments caused an increase in C - peptide .